Myopharm Limited logo

Myopharm Limited jobs and careers

As of October 24, 2026, Myopharm Limited has no open roles listed.

About Myopharm Limited

Myopharm is an IND stage biotechnology company focused on developing first in class, novel therapeutics for the treatment and prevention of Type 2 diabetes. Myopharm is currently developing a number of diabetes therapeutics including a beta-cell-centric dual combination drug, to address the 50% antidiabetic treatment failures occurring in Type 2 diabetics. Right now, there are no anti-inflammatory 'Beta-cell-centric' therapies on the market for Type 2 diabetes. Our novel & innovative beta-cell centric product, RK-01 or TriGlytza™ restored the efficacy of Metformin in C57BL/6J DIO mice with insulin resistance and pancreatic beta-cell dysfunction. We are on track to bring TriGlytza™ to market by 2027. https://www.myopharm.com

Founded
2020
Employees
11 to 50

Leadership

The top of Myopharm Limited's org chart, with how many people report into each leader.

CCPhoto of Charles Czank

Charles Czank

Head of Clinical Development

1 report

AP

Advait Padhye

Research Associate

Jobs at Myopharm Limited

No open positions right now. Explore more companies on TheJobsMap.

Myopharm Limited jobs: common questions

Is Myopharm Limited hiring right now?
Myopharm Limited has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Myopharm Limited's careers site.
Who leads Myopharm Limited?
Charles Czank, Head of Clinical Development, is at the top of Myopharm Limited's org chart.
How do I apply for a job at Myopharm Limited?
Pick a role on Myopharm Limited's TheJobsMap page and select Apply. Every listing links to the original posting on Myopharm Limited's own careers site, so you apply directly with the employer.